Cargando…
COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875834/ https://www.ncbi.nlm.nih.gov/pubmed/36228295 http://dx.doi.org/10.1097/TP.0000000000004418 |
| _version_ | 1784878037345501184 |
|---|---|
| author | Cochran, Willa Salto-Alejandre, Sonsoles Barker, Lindsay Langlee, Julie Freed, Kristin Carter, Debra Bannon, Jaclyn Goddard, Dillon Mostafa, Heba Werbel, William Shah, Pali Segev, Dorry Brennan, Daniel Avery, Robin |
| author_facet | Cochran, Willa Salto-Alejandre, Sonsoles Barker, Lindsay Langlee, Julie Freed, Kristin Carter, Debra Bannon, Jaclyn Goddard, Dillon Mostafa, Heba Werbel, William Shah, Pali Segev, Dorry Brennan, Daniel Avery, Robin |
| author_sort | Cochran, Willa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9875834 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98758342023-01-27 COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge Cochran, Willa Salto-Alejandre, Sonsoles Barker, Lindsay Langlee, Julie Freed, Kristin Carter, Debra Bannon, Jaclyn Goddard, Dillon Mostafa, Heba Werbel, William Shah, Pali Segev, Dorry Brennan, Daniel Avery, Robin Transplantation Letters to the Editor Lippincott Williams & Wilkins 2022-10-13 2023-02 /pmc/articles/PMC9875834/ /pubmed/36228295 http://dx.doi.org/10.1097/TP.0000000000004418 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letters to the Editor Cochran, Willa Salto-Alejandre, Sonsoles Barker, Lindsay Langlee, Julie Freed, Kristin Carter, Debra Bannon, Jaclyn Goddard, Dillon Mostafa, Heba Werbel, William Shah, Pali Segev, Dorry Brennan, Daniel Avery, Robin COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge |
| title | COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge |
| title_full | COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge |
| title_fullStr | COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge |
| title_full_unstemmed | COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge |
| title_short | COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge |
| title_sort | covid-19 outcomes in solid organ transplant recipients who received tixagevimab-cilgavimab prophylaxis and/or bebtelovimab treatment in a nurse-driven monoclonal antibody program during the omicron surge |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875834/ https://www.ncbi.nlm.nih.gov/pubmed/36228295 http://dx.doi.org/10.1097/TP.0000000000004418 |
| work_keys_str_mv | AT cochranwilla covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT saltoalejandresonsoles covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT barkerlindsay covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT langleejulie covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT freedkristin covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT carterdebra covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT bannonjaclyn covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT goddarddillon covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT mostafaheba covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT werbelwilliam covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT shahpali covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT segevdorry covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT brennandaniel covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge AT averyrobin covid19outcomesinsolidorgantransplantrecipientswhoreceivedtixagevimabcilgavimabprophylaxisandorbebtelovimabtreatmentinanursedrivenmonoclonalantibodyprogramduringtheomicronsurge |